End-of-day quote
Korea S.E.
18:00:00 2024-05-19 EDT
|
5-day change
|
1st Jan Change
|
1,681
KRW
|
-0.71%
|
|
-0.88%
|
-22.71%
|
2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
| 2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
|
|
2024-05-13
|
2024-05-14
|
2024-05-16
|
2024-05-17
|
2024-05-20
|
Last |
1696 ₩
|
1700 ₩
|
1691 ₩
|
1693 ₩
|
1681 ₩
|
Volume |
157 973 |
118 669 |
194 537 |
136 590 |
213 068 |
Change |
+∞%
|
+0.24%
|
-0.53%
|
+0.12%
|
-0.71%
|
Opening |
1,699.00 |
1,690.00 |
1,702.00 |
1,682.00 |
1,693.00 |
High |
1,700.00 |
1,709.00 |
1,713.00 |
1,696.00 |
1,703.00 |
Low |
1,685.00 |
1,688.00 |
1,690.00 |
1,682.00 |
1,678.00 |
Avg. Volume 20 sessions
161 009
Avg. Volume 20 sessions KRW
270 656 129.00
Avg. Volume 20 sessions USD
198 661.60
Record volume 1
84 880 220
Record volume 2
74 058 590
Record volume 3
57 523 550
Capital turnover ratio
0.00
Capitalization (KRW)
158 478 855 586
Capitalization (USD)
116 323 480
Net sales (KRW)
46 483 649 020
Net sales (USD)
34 118 998
Sales / Employee (KRW)
193 681 871
Sales / Employee (USD)
142 162
Free-Float capitalization (KRW)
141 849 700 688
Free-Float capitalization (USD)
104 117 680
Average Daily Capital Traded
0.17%
Moving average 5 days
1 692.20
Moving average 20 days
1 682.90
Moving average 50 days
1 741.94
Moving average 100 days
1 946.54
Price spread / (MMA5) +0.67% Price spread / (MMA20) +0.11% Price spread / (MMA50) +3.63% Price spread / (MMA100) +15.80%
More charts
|